Critical neurological conditions: severe toxic polyneuropathy with the development of respiratory failure and rhabdomyolysis

Abstract

This is a description of the clinical case of severe toxic polyneuropathy in a 52-year-old man, caused by a confirmed exogenous intoxication with amphetamine.

The clinical picture was remarkable for muscle weakness in different muscle groups: neck, back, arms and legs, respiratory muscles; as well as for the respiratory failure (requiring mechanical ventilation), rhabdomyolysis, mild nephropathy, liver cytolysis. A differential diagnosis was made between myasthenia gravis, myopathy, amyotrophic lateral sclerosis. After a course of intensive therapy, almost complete regression of symptoms took place, as well as the improvement of electroneuromyographic pattern. Taking into account a rapid partial regression of symptoms in the course of the disease, as well as the results of a neurophysiological study, an immunochromatographic urine drug screen was performed, positive for amphetamine. This clinical case demonstrates "rare" complications of amphetamine use to be kept in mind during a diagnostic search.

About the authors

Yulia V. Ryabinkina

Research Center of Neurology, Moscow

Author for correspondence.
Email: platonova@neurology.ru
Russian Federation

Maria N. Zakharova

Research Center of Neurology, Moscow

Email: platonova@neurology.ru
Russian Federation

Roman V. Polishchuk

Research Center of Neurology, Moscow

Email: platonova@neurology.ru
Russian Federation

Irina E. Luneva

Research Center of Neurology, Moscow

Email: platonova@neurology.ru
Russian Federation

Eduard V. Pavlov

Research Center of Neurology, Moscow

Email: platonova@neurology.ru
Russian Federation

Mikhail A. Piradov

Research Center of Neurology, Moscow

Email: platonova@neurology.ru
Russian Federation

References

  1. [The main indicators of the narcological service in the Russian Federation in 2014–2015: statistical sourcebook]. Мoscow; 2016. (In Russ.)
  2. Fedorov G.V. [Counteraction to illegal circulation of narcotic drugs, psychotropic substances and their precursors among minors and youth]. Vestnik Polotskogo gosudarstvennogo universiteta. Seriya D: ekonomicheskie i yuridicheskie nauki 2009; (10): 211–215. (In Russ.)
  3. Shanin I.A., Khan O.Yu., Petukhov A.E. [Detection of amphetamines in urine using immunochromatographic test strips]. Sudebno-meditsinskaya ekspertiza 2012; 55(4): 33–37. (In Russ.)
  4. Beck О., Kraft M., Moeller M.R. et al. Frontline immunochromatographic device for on-site urine testing of amphetamines: laboratory validation using authentic specimens. Ann Clin Biochem 2000; 37 (Pt. 2): 199–204. doi: 10.1258/0004563001899005. PMID: 10735364.
  5. Connell P.H. Clinical manifestations and treatment of amphetamine type of dependence. JAMA 1966; 196: 718–723.
  6. Albertson T.E., Walby W.F., Derlet R.W. Stimulant-induced pulmonary toxicity. Chest 1995; 108: 1140–1149. PMID: 7555128.
  7. Pothos E.N., Creese I., Hoebell B.G. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J Neurosci 1995;
  8. (10): 6640–6650. PMID: 7472425.
  9. Koren’ E.V., Kupriyanova T.A. [Hyperkinetic disorders (ADHD): clinical recommendations]. Мoscow; 2015. (In Russ.)
  10. Crisostomo E.A., Duncan P.W., Propst M. et al. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988. doi: 10.1002/ana.410230117. PMID: 3345072.
  11. Connell P.H. Amphetamine psychosis. Br Med J 1957; 1: 582.
  12. Parkes J.D., Fenton G.W. Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. J Neurol Neurosurg Psychiatry 1973; 36: 1076–1081. PMID: 4359162.
  13. Albertson T.E., Derlet R.W., Van Hoozen B.E. Methamphetamine and the expanding complications of amphetamines. West J Med 1999; 170: 214–219. PMID: 10344175.
  14. Garwood E.R., Bekele W., McCulloch C.E. , Christine C.W. Amphetamine exposure is elevated in Parkinson’s disease. Neurotoxicology 2006; 27: 1003–1006. doi: 10.1016/j.neuro.2006.03.015. PMID: 16620991.
  15. Curtin K., Fleckenstein A.E., Robison R.J. et al. Methamphetamine/amphetamine abuse and risk of Parkinson’s disease in Utah: A population-based assessment. Drug Alcohol Depend 2015; 146: 30–38. doi: 10.1016/j.drugalcdep.
  16. 10.027. PMID: 25479916.
  17. Stafford C.R., Bogdanoff B.M., Green L., Spector H.B. Mononeuropathy multiplex as a complication of amphetamine angiitis. Neurology 1975; 25: 570–572. PMID: 165440.
  18. Citron B.P., Halpern M., McCarron M. et al. Necrotizing angiitis a ssociated with drug abuse. N Engl J Med 1970; 283: 1003–1011. DOI: 10.1056/ NEJM197011052831901. PMID: 4394271

Statistics

Views

Abstract: 974

PDF (Russian): 496

Article Metrics

Metrics Loading ...

Dimensions

PlumX


Copyright (c) 2018 Ryabinkina Y.V., Zakharova M.N., Polishchuk R.V., Luneva I.E., Pavlov E.V., Piradov M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies